These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3408645)

  • 1. Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
    Smith MA; Merry S; Smith JG; Kaye SB
    Br J Cancer; 1988 Jun; 57(6):576-8. PubMed ID: 3408645
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
    Yalowich JC; Zucali JR; Gross M; Ross WE
    Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
    Cavazzana M; Calvo F; Facchin P; Barreau P; Geny B; Dal Cortivo L; Dresch C
    Exp Hematol; 1988 Nov; 16(10):876-83. PubMed ID: 3169155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium antagonists on anti-cancer drug toxicity to haematopoietic progenitor cells in normal human bone marrow.
    Nakarai T; Koizumi S
    Leuk Res; 1990; 14(5):401-5. PubMed ID: 2345465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.
    Busch FW; Schmittele U; Ehninger G
    Blut; 1990 Apr; 60(4):219-22. PubMed ID: 2337680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ; Aihara M; Blume KG; Sikic BI
    Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
    Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs.
    Fine RL; Koizumi S; Curt GA; Chabner BA
    J Clin Oncol; 1987 Mar; 5(3):489-95. PubMed ID: 3819811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulindac on myeloid precursors growth in vitro.
    Torres A; Gómez P; Martínez-Sánchez F; Bayón P; Manzanares R; Prieto B
    Methods Find Exp Clin Pharmacol; 1984 Feb; 6(2):63-5. PubMed ID: 6717172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study.
    Miller G; Brashear T; Stone M; Fay J
    Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
    Aihara M; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1990 Sep; 18(8):940-4. PubMed ID: 2387345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    Young JW; Szabolcs P; Moore MA
    J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
    Stiff PJ; Koester AR
    Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Tocopherol pretreatment increases adriamycin bone marrow toxicity.
    Alberts DS; Peng YM; Moon TE
    Biomedicine; 1978 Oct; 29(6):189-91. PubMed ID: 737277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.